Japan Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Japanese pharmaceuticals market had total revenues of $92.3 billion in 2022, representing a compound annual growth rate (CAGR) of 9% between 2017 and 2022.
- 0
- The Japanese market acquired a 21.7% share of the Asia-Pacific pharmaceuticals market in 2022. The Japanese government is aiming to revive its pharmaceutical industry by implementing changes to pricing policies that support access to innovative medicines. The country has reduced the drug lag by prioritizing consultation, rapid review, premium drug pricing, and an extended data protection period.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts
- What was the size of the Japan pharmaceuticals market by value in 2022?
- What will be the size of the Japan pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Japan pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the most recent market developments?
- 8 Company Profiles
- 8.1. Daiichi Sankyo Co Ltd
- 8.2. Astellas Pharma Inc.
- 8.3. Takeda Pharmaceutical Company Limited
- 8.4. Mitsubishi Tanabe Pharma Corporation
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Japan pharmaceuticals market value: $ billion, 2017-22
- Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2022
- Table 3: Japan pharmaceuticals market value forecast: $ billion, 2022-27
- Table 4: Daiichi Sankyo Co Ltd: key facts
- Table 5: Daiichi Sankyo Co Ltd: Annual Financial Ratios
- Table 6: Daiichi Sankyo Co Ltd: Key Employees
- Table 7: Daiichi Sankyo Co Ltd: Key Employees Continued
- Table 8: Astellas Pharma Inc.: key facts
- Table 9: Astellas Pharma Inc.: Annual Financial Ratios
- Table 10: Astellas Pharma Inc.: Key Employees
- Table 11: Takeda Pharmaceutical Company Limited: key facts
- Table 12: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
- Table 13: Takeda Pharmaceutical Company Limited: Key Employees
- Table 14: Takeda Pharmaceutical Company Limited: Key Employees Continued
- Table 15: Mitsubishi Tanabe Pharma Corporation: key facts
- Table 16: Japan size of population (million), 2018-22
- Table 17: Japan gdp (constant 2005 prices, $ billion), 2018-22
- Table 18: Japan gdp (current prices, $ billion), 2018-22
- Table 19: Japan inflation, 2018-22
- Table 20: Japan consumer price index (absolute), 2018-22
- Table 21: Japan exchange rate, 2018-22
- List of Figures
- Figure 1: Japan pharmaceuticals market value: $ billion, 2017-22
- Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2022
- Figure 3: Japan pharmaceuticals market value forecast: $ billion, 2022-27
- Figure 4: Forces driving competition in the pharmaceuticals market in Japan, 2022
- Figure 5: Drivers of buyer power in the pharmaceuticals market in Japan, 2022
- Figure 6: Drivers of supplier power in the pharmaceuticals market in Japan, 2022
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2022
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2022
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook